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ABSTRACT 
Objective: To evaluate the anti-inflammatory activity of the ethanolic leaf extract of Barleria montana (B. montana) against formalin induced 
inflammation. 
Methods: Male albino wistar rats were pretreated with oral doses of 100 mg, 200 mg and 300 mg of the extract for 30 days and the animals 
received a single dose of sub plantar injection of formalin (0.1 ml/kg body weight (bw.)) Indomethacin (25 mg/kg bw.) was used as the standard 
drug. The effect of the extract on paw thickness, biochemical and hematological parameters was investigated along with histopathological studies.  
Results: The results revealed that the extract exhibited an effective dose dependent activity against formalin induced inflammation with a 
maximum activity at a dosage of 300 mg/kg bw. which was comparable with the standard drug. 
Conclusion: The results signify promising activity of ethanolic leaf extract of B. montana against formalin induced inflammation in albino rats. The 
extract was also found to exhibit appreciable antioxidant activity. 
Keywords: Barleria montana, Formalin, Inflammation, Indomethacin. 
 
INTRODUCTION 
Inflammation, despite being a defense mechanism can induce, 
maintain or aggravate many diseases such as asthma, arthritis and 
other autoimmune diseases with its complex events and mediators 
involved in the inflammatory reaction [1]. Over the years the role of 
inflammation in the pathogenesis of atherosclerosis [2], insulin 
resistance [3], tumour progression and that many cancers arise from 
sites of infection, chronic irritation and inflammation [4] have been 
well documented. Growing evidence also shows that inflammation 
not only contributes to cancer development, but also affects 
chemotherapy efficacy and resistance [5]. In such cases, the defense 
reaction themselves may cause progressive tissue injury and hence, 
anti-inflammatory or immunosuppressive drugs may be necessary 
to modulate the inflammatory process [6]. 
Medications that work to reduce inflammation come in two major 
categories: Steroids and Non-steroidal anti-inflammatory drugs 
(NSAIDs). However, while long-term use of corticosteroids are 
known to cause several severe side effects like hyperglycemia, 
insulin resistance, diabetes mellitus and osteoporosis [7], prolonged 
use of NSAIDs can injure the gastric and duodenal mucosa leading to 
considerable morbidity and mortality [8]. These negative effects of 
commercial anti-inflammatory drugs make them untenable for long-
term treatment of inflammation and have prompted the need for 
alternative anti-inflammatory medicines with the highest efficacy 
and less or no side effects. 
Encompassing approximately 6000 medicinal plant species, the 
medicinal flora of Asia and Pacific comprises a fantastic source of 
pharmacologically active products and the number of plant species 
principally used for the treatment of inflammation can be estimated 
to be more than 380 [9]. Phyto compounds from plants such as 
polyphenols, flavonoids, terpenes, quinines, catechins, and alkaloids 
have been screened for their capacity to modulate the expression of 
pro-inflammatory signals thereby assessing their capacity as anti-
inflammatory agents. However, there are many more medicinal 
plants whose anti-inflammatory potential has not yet been explored.  
B. montana (Acanthaceae) is an erect herb, growing on exposed 
slopes and among rocks in the hills predominantly found in the 
mountains of Western Ghats and sparsely in Eastern Ghats. Alkaloids, 
terpenoids, flavonoids, tannins, coumarin, sterol and quinine have been 
reported in this plant with flavonoids and irudoid glycosides being the 
predominant phytoconstituents [10]
Wistar strain of albino rats weighing 120g-150g were obtained from 
Tamilnadu Veterinary and Animal Sciences University, Chennai. 
They were fed with standard rat chow pellet obtained from Sai 
Durga Food and Feeds, Bangalore, India and water ad libitum. 
Animals were maintained in a standard animal house in a controlled 
environment (temperature 25+2 °C and 12h dark/light cycle). The 
study was conducted after obtaining the necessary clearance from 
Institutional Animal Ethical Committee. 
. Even though B. montana has been 
traditionally used for centuries for treating wounds, diabetes, cough, 
inflammation and is also known to possess hepatoprotective activity 
[10] its anti-inflammatory activity has not been explored. Hence the 
present study aims to evaluate the anti-inflammatory activity of B. 
montana against formalin induced inflammation. 
MATERIALS AND METHODS 
Plant material 
Fresh leaves of B. montana Wight & Nees were collected from Kolli 
Hills, Eastern Ghats, identified by Prof. Dr. P. Jayaraman, Director, 
Institute of Herbal Botany, Plant Anatomy Research Centre, Chennai, 
Tamilnadu and authenticated with the specimens deposited at 
RAPINAT Herbarium (RHT), Department of Botany, St. Joseph’s 
college, Tiruchirappalli.  
Preparation of plant extract 
The plant material (Leaf) was shade dried and coarsely powdered. 
About 500 g of plant material was soaked in ethanol for 48h. After 
48h of soaking the solvent was distilled off under reduced pressure 
and dried in vacuum condition.  
Experimental animals 
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Experimental design 
Group I Normal male albino wistar rats 
Group II Received sub-plantar injection of 0.1 ml/kg bw. of formalin 
Group III Pretreated with ethanolic leaf extract of B. montana (100 mg/kg bw.) (Single dosage of formalin on 30th
Group IV 
 day) 
Pretreated with ethanolic leaf extract of B. Montana (200 mg/kg bw.) (Single dosage of formalin on 30th
Group V 
 day).  
Pretreated with ethanolic leaf extract of B. Montana (300 mg/kg bw.) (Single dosage of formalin on 30th
Group VI 
 day). 
Treated with formalin+standard drug indomethacin (25 mg/kg bw.) 
 
Measurement of paw edema 
The increase in paw edema was measured by Vernier caliper 
method [11]. The paw thickness was measured before and 6 days 
after induction of inflammation by using Vernier caliper. The 
difference in paw thickness after and before induction of 
inflammation was calculated and presented as a mean increase in 
paw thickness (mm). The ability of anti-inflammatory drug to 
suppress paw inflammation was expressed as a percentage of 
inhibition of paw edema [12] and this percentage can be calculated 
according to the following equation:  
Percentage of inhibition (%) = 100 × (1-X/Y). 
Where, X = mean increase in paw volume, thickness or weight of 
treated rats  
Y = mean increase in paw volume, thickness or weight of control 
rats.  
Biochemical investigation 
The levels of enzymatic antioxidants like reduced glutathione (GSH) 
[13], glutathione peroxidase (GPx) [14], superoxide dismutase (SOD) 
[15] and non-enzymatic antioxidant lipid peroxide (LPO) [16] were 
assessed. Serum levels of marker enzymes aspartate transaminase 
(SGOT) [17], alanine transaminase (SGPT) [17], alkaline 
phosphatase (ALP) [17] and creatine kinase (CK) [18] were 
estimated.  
Haematological investigation 
The level of Hemoglobin (Hb) [19] was determined and 
enumerations of red blood cells (RBC), white blood cells (WBC) [19], 
neutrophils, eosinophils, lymphocytes and basophils [20] were also 
done. 
Histopathological studies 
Histology of the liver tissues was performed by the method of [21]. 
Statistical analysis 
All the results were expressed as mean±Standard Error of Mean±SEM. 
The data was statistically analyzed by one–way analysis of variance 
(ANOVA). P values<0.05 were considered as significant. 
RESULTS  
Effect of ethanolic leaf extract of B. montana on paw thickness 
In the present study, subcutaneous injection of diluted formalin 
into a hind paw elicited a biphasic pattern of pain-related 
behaviors, an early short-lasting neurogenic phase followed by a 
second and more sustained inflammatory phase when compared 
with normal control groups. However, pretreatment with ethanol 
leaf extract of Barleria montana showed a significant inhibition 
(p<0.05) in the late phase of formalin induced pain in a dose 
dependent manner which was well comparable with the standard 
indomethacin (table 1). 
 
Table 1: Effect of ethanolic leaf extract of B. montana on paw thickness 
Groups  Paw thickness (cm2) 





Group IV 1.09±1.78 




*-Significant when compared between Group 1 and Group 2 (p≤ 0.05, n=6), **-Significant when compared between Group 2 and Group 5 (p≤ 0.05, 
n=6), a-Significant when compared between Group2, Group 5 and Group 6 (p≤ 0.05, n=6) , b-Non significant when compared between Group 5 and 
Group 6 (p≤0.01, n=6) 
 
Effect of ethanolic leaf extract of B. montana on the antioxidant 
status of the experimental models 
In the present study formalin induced experimental animals showed 
a decrease in the levels of antioxidant enzymes which had a direct 
impact on the levels of lipid peroxide (LPO) when compared with 
normal control groups indicating tissue damage. Pretreatment with 
ethanolic leaf extract of B. montana resulted in a significant increase 
(p<0.05) in the enzymatic antioxidant values and decrease in the 
LPO levels when compared with the standard drug treated groups, 
which are an indication of the antioxidant property of B. montana 
(table 2). 
 
Table 2: Effect of ethanolic leaf extract of B. montana on antioxidant status and LPO levels 
 Groups 
 
 Superoxide dismutase 
(mM of epinephrine 
oxidized/min/g tissue) 
Glutathione peroxidase 




(nmoles of mda/g tissue) 
 Group I  12.19±0.07  4.85±0.04*  18.15±0.01* 215.41±2.40* * 
 Group II  4.60±0.08  1.16±0.05*,**,a  8.66±0.60*,**,a 636.20±1.58*,**,a 
 Group III 
*,**,a 
 7.46±0.05  2.40±0.05  12.23±0.07 561.85±1.78 
 Group IV  9.87±0.07  4.12±0.04  16.35±0.07 425.67±1.51 
 Group V   11.87±0.05  4.71±0.03**,a,b  17.98±0.05**,a,b 241.26±1.09**,a,b 
 Group VI 
**,a,b 
 12.02±0.06  4.93±0.03 a,b  18.07±0.05 a,b 217.25±1.78 a,b a,b 
*-Significant when compared between Group 1 and Group 2 (p≤ 0.05, n=6), **-Significant when compared between Group 2 and Group 5 (p≤ 0.05, 
n=6), a-Significant when compared between Group2, Group 5 and Group 6 (p≤ 0.05, n=6) , b-Non significant when compared between Group 5 and 
Group 6 (p≤0.01, n=6) 
Sridharan et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 9, 80-84 
82 
Effect of ethanolic leaf extract of B. montana on Hb, RBC and 
WBC levels 
Decreased levels of Hb and RBC were well observed in formalin 
induced experimental rats when compared with normal control 
groups which however on pretreatment with ethanolic leaf extract 
of B. montana in a dose dependent manner showed significant 
progress (p<0.05) in the levels of Hb and RBC which was well 
comparable with the standard drug treated rats (table 3). Similar 
results were observed in WBC levels. 
 
Table 3: Effect of ethanolic leaf extract of B. montana on Hb, RBC and total WBC levels 
 Groups  Hb (g %)  RBC  millions of cells/mm  Total WBC 1000's of cells/mm3 3 
 Group I  13.21±2.20  5.87±0.12*  4.01±4.56* * 
 Group II  9.16±1.45  3.33±0.25*,**,a  8.12±5.63*,**,a 
 Group III 
*,**,a 
 10.12±0.16  4.51±0.10  7.23±6.16 
 Group IV  11.97±0.23  4.93±0.09  5.64±2.96 
 Group V   12.97±0.07  5.57±0.12**,a,b  4.31±2.86**,a,b 
 Group VI 
**,a,b 
 13.30±0.24  5.87±0.05 a,b  4.17±3.03 a,b a,b 
*-Significant when compared between Group 1 and Group 2 (p≤ 0.05, n=6), **-Significant when compared between Group 2 and Group 5 (p≤ 0.05, 
n=6), a-Significant when compared between Group2, Group 5 and Group 6 (p≤ 0.05, n=6) , b-Non significant when compared between Group 5 and 
Group 6 (p≤0.01, n=6) 
 
Effect of ethanolic leaf extract of B. montana on neutrophils, 
lymphocytes, eosinophils and basophil levels 
The present investigation showed elevated levels of neutrophils, 
lymphocytes, eosinophils and basophils in formalin induced 
experimental animals when compared with normal control groups. 
However, there was a significant reduction (p<0.05) in the 
population of neutrophils, eosinophils, lymphocytes and basophils in 
experimental rats pretreated with ethanolic leaf extract of B. 
montana which was well comparable with the standard drug treated 
groups (table 4). 
Effect of ethanolic leaf extract of B. montana on serum marker 
enzyme and creatine kinase levels 
In the present study, increased levels of SGOT, SGPT and ALP were 
observed in formalin induced animals when compared with normal 
control groups which subsequently decreased (p<0.05) on dose 
dependent pretreatment with ethanolic leaf extract of B. montana 
which was well comparable with the standard drug treated groups 
indicating inhibition of inflammation. Creatine kinase, was found to 
be increased in formalin induced groups but was subsequently 
decreased on pretreatment with ethanolic leaf extract of B. montana 
at dose levels of 100, 200, 300 mg/kg bw. whose effect was on par 
with the standard drug treated groups (table 5). 
Histopathological studies 
Histopathological sections of normal rat paw showed a normal 
architectural pattern of cartilage and osteoblast. The edematous 
tissue section of formalin induced rats showed a loss of cartilage, 
osteoblast hyperplasia and accumulation of abundant mono and 
poly morpho nuclear cells in the joint and congestion of vessels 
and loss of marrow and disarray, which were everted back to 
normalcy on pretreatment with ethanolic leaf extract of B. 
montana (fig. 1). 
 
 
Fig. 1: Histopathological studies–Inflammation 
 
(a) Normal hind paw of albino wistar rats showing normal architectural pattern of cartilage and osteoblast. (b) Edematous tissue section of formalin 
induced rats showing a loss of cartilage, osteoblast hyperplasia, and accumulation of abundant mono and poly morpho nuclear cells in the joint and 
congestion of vessels and loss of marrow and disarray. (c) Ethanolic leaf extract of B. montana (300 mg/kg bw.) pretreated albino wistar rats 
showing moderate reduction in the cartilage. No osteoblast hyperplasia, moderate accumulation of mono and poly morpho nuclear cells in the joint, 
healing of vessels and gain of marrow in formalin induced experimental rats (d) Edematous tissue section of formalin induced rats treated with 
standard drug indomethacin showing normal architectural pattern of cartilage and osteoblast. Magnification-250 X,Stain: Haematoxylin-Eosin stain. 
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Table 4: Effect of ethanolic leaf extract of B. montana on neutrophils, lymphocytes, eosinophil and basophil levels 
Groups Neutrophils (%) Lymphocytes (%)  Eosinophils (%) Basophils (%) 
Group I  54.36±0.17  41.13±0.08*  4.16±0.06* 1.16±0.06* * 
Group II 87.40±1.67  63.52±0.17*,**,a  7.79±0.07*,**,a 4.18±0.07*,**,a 
Group III 
*,**,a 
 79.36±0.23  56.48±0.27  6.19±0.06 3.19±0.06 
Group IV 66.85±0.22  50.80±0.05  5.73±0.08 2.73±0.08 
Group V  60.37±0.18 44.61±0.17**,a,b  3.98±0.09**,a,b 1.98±0.09**,a,b 
Group VI 
**,a,b 
 56.26±0.33  42.13±0.06 a,b  3.51±0.06 a,b 1.51±0.06 a,b a,b 
*-Significant when compared between Group 1 and Group 2 (p≤ 0.05, n=6), **-Significant when compared between Group 2 and Group 5 (p≤ 0.05, 
n=6), a-Significant when compared between Group2, Group 5 and Group 6 (p≤ 0.05, n=6), b -Non significant when compared between Group 5 and 
Group 6 (p≤0.01, n=6) 
 
Table 5: Effect of ethanolic leaf extract of B. montana on Serum marker enzyme and Creatine kinase levels 
 Groups  SGOT (IU/l)  SGPT (IU/l)  ALP (IU/l)  CK(IU/l) 
 Group I  37.97±1.69  34.16±1.39*  99.77±1.89*  278.56±1.78* * 
 Group II  89.89±1.96  78.89±1.77*,**,a  229.97±1.75*,**,a  479.99±1.69*,**,a 
 Group III 
*,**,a 
 76.79±1.55  73.86±1.57  196.83±1.81  384.76±1.86 
 Group IV  69.99±1.79  55.69±1.97  186.36±1.87  318.75±1.72 
 Group V  59.88±1.97  48.59±1.87**,a,b  141.47±1.98**,a,b  269.46±1.56**,a,b 
 Group VI 
**,a,b 
 38.45±1.52  33.39±1.89 a,b  110.85±1.76 a,b  238.45±1.78a,b a,b 
*-Significant when compared between Group 1 and Group 2 (p≤ 0.05, n=6), ** -Significant when compared between Group 2 and Group 5 (p≤ 0.05, 
n=6), a-Significant when compared between Group2, Group 5 and Group 6 (p≤ 0.05, n=6), b -Non significant when compared between Group 5 and 
Group 6 (p≤0.01, n=6) 
 
DISCUSSION 
The formalin method is an important animal model in the study of 
acute long-lasting inflammatory pain. A reduction in paw swelling 
size is a good index in determining the protective action of anti-
inflammatory agents [22]. In the present study, sub-cutaneous 
injection of diluted formalin into a hind paw elicited a biphasic 
pattern of pain-related behaviors, an early short-lasting neurogenic 
phase followed by a second and more sustained inflammatory phase. 
However, pretreatment with ethanolic leaf extract of B. montana 
showed a significant inhibition in the late phase of formalin induced 
pain in a dose-dependent manner which was well comparable with 
the standard indomethacin and also corroborated with the findings 
of [22].  
Free radical production that occurs during development of 
inflammation in the cartilage leads to decreased GSH, GPx, and SOD 
levels as a result of their consumption during oxidative stress and 
cellular lysis. Reactive oxygen species (ROS) destroy antioxidant 
systems leading to oxidative damage and lipid peroxidation because 
of the reduced endogenous antioxidant defense system [23]. This 
decrease contributes to increased cellular damage by favoring an 
attack by free radicals. The present study has shown similar findings 
with depleted levels of antioxidants and increased level of LPO in 
formalin induced rats showing loss of cellular integrity, but 
pretreatment with ethanolic leaf extract of B. montana significantly 
reversed the depleted levels of antioxidants, probably by competing 
with scavenging of free radicals and as a result helped to maintain 
the integrity of cellular membranes in the injured cartilage. 
Flavonoids, which were found to be higher in ethanolic leaf extract 
of B. montana can act as an antioxidant because of its ability to 
scavenge free radicals. 
Cytokines produced by neutrophils are good indicators of 
progressive inflammation as neutrophils are important sources of 
free radicals at the site of inflammation [24]. A notable increase in 
the population of neutrophils in the present study was suggestive of 
propagation of inflammation, which was well reduced and reverted 
close to normalcy in groups pretreated with ethanolic leaf extract of 
B. montana with increasing concentrations. Eosinophils are 
granulated molecules that release lipid derived mediators which 
stimulate responses in tissues, which are indicative of inflammation. 
They act as important marker molecules in infectious conditions. 
The present investigation showed an elevated level in their count 
indicative of the release of cytokines and interleukins in formalin 
induced experimental animals accounting to inflammation. 
However, the pretreated groups showed a good reduction in the 
population of eosinophils that indicate the restoration of normal 
tissues. Lymphocyte is the predominant cell in chronic 
inflammation. It can cause permanent distortion of the tissue. 
Elevated levels of lymphocytes were observed in formalin induced 
experimental rats indicative of tissue damage,which was reversed in 
pretreated groups. Basophils appear in many specific kinds of 
inflammatory reactions, particularly those that cause allergic 
symptoms. They can be found in unusually high numbers at sites of 
inflammation which was well observed in the formalin induced rats 
[25]. However, the pretreated groups showed a good reduction in 
the population of basophils. The reduction in the population of 
neutrophils, eosinophils, lymphocytes and basophils in formalin 
induced rats pretreated with ethanolic leaf extract of B. montana 
shows its anti-inflammatory property.  
Low concentrations of Hb and RBC are important patho-
physiological alterations noted in chronic inflammatory diseases 
such as rheumatoid arthritis, which is commonly associated with 
conditions of anoxia. This depletion in the levels of Hb and RBC was 
well observed in formalin induced experimental rats suggestive of 
the fact that there was a low supply of oxygen to the injured tissues. 
Such a decline in the levels of Hb and RBC was also reported by Hull 
et al., 2003 [26]. Pretreatment with ethanolic leaf extract of B. 
montana in a dose-dependent manner showed good progress in the 
levels of Hb and RBC indicating less necrosis and regeneration of 
normal tissues, which was well comparable with the standard drug 
treated rats. 
WBC plays an inevitable role in body’s defense mechanism. The 
increase in WBC count during inflammation may be due to the 
release of interleukins, responsible for the production of both 
granulocytes and macrophage colony stimulating factor [27]. In the 
present study, the level of WBC was found to be higher in formalin 
induced experimental animals. Pretreatment with ethanolic leaf 
extract of B. montana at the dose levels of 100, 200, 300 mg/kg bw. 
effectively reduced the WBC count that indicated recovery from the 
inflammatory process. 
Most of the anti-inflammatory drugs exert their beneficial effect by 
inhibiting either release of lysosomal enzymes or by stabilizing 
lysosomal membrane, which is one of the major events responsible 
for the inflammatory process. The increased levels of lysosomal 
enzymes like SGOT, SGPT and ALP in case of inflammation are good 
indicators of liver and kidney impairment [28]. In the present study, 
pretreatment with ethanolic leaf extract of B. montana at dose levels 
Sridharan et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 9, 80-84 
84 
of 100, 200 and 300 mg/kg bw. decreased the levels of SGOT, SGPT, 
ALP that had increased after formalin induction. 
Creatine kinase is an important serum marker enzyme that is often 
used as an important diagnostic tool to ascertain the severity of 
necrosis or tissue damage. A rapid increase in the concentrations of 
creatine kinase is directly related to irreversible tissue injury [29]. A 
two-fold increase in formalin induced experimental animals was 
observed in the present study, indicative of tissue damage which on 
pretreatment with ethanolic leaf extract of B. montana showed 
reversion to normalcy in a dose-dependent manner. 
Histological studies carried out in rats following pretreatment with 
ethanolic leaf extract of B. montana, especially at a dosage of 300 
mg/kg bw. revealed down regulation of the inflammatory infiltration 
with associated tissue damages showing reduction in the cartilage, 
no osteoblast hyperplasia, moderate accumulation of abundant 
mono and poly morpho nuclear cells in the joint, healing of vessels 
and gain of marrow in formalin induced rats as compared to 
untreated rats. This change may also be attributed due to 
restoration of the antioxidant status reflected in the biochemical 
parameters [25]. 
CONCLUSION 
The results obtained in the present study clearly indicate a 
promising anti-inflammatory activity of ethanolic leaf extract of 
Barleria montana against formalin induced inflammation in albino 
rats. The extract was also found to exhibit appreciable antioxidant 
activity which can be considered as a contributing factor to its 
biological activity. However, further studies are needed to isolate the 
phyto compound(s) present in this plant and to evaluate their anti-
inflammatory activity. 
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